uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Slow internalization of anti-HER2 synthetic affibody monomer 111In-DOTA-ZHER2:342-pep2: implications for development of labeled tracers
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology, Biomedical Radiation Sciences. (BMS)ORCID iD: 0000-0001-6120-2683
2008 (English)In: Cancer Biotherapy and Radiopharmaceuticals, ISSN 1084-9785, Vol. 23, no 4, 435-442 p.Article in journal (Refereed) Published
Abstract [en]

Affibody molecules are a novel class of targeting proteins, demonstrating promising results in the molecular imaging of tumor markers. The aim of this study was to investigate the cellular processing of Affibody molecules bound to human epidermal growth-factor-receptor type 2 (HER2). Cellular processing of the synthetic Affibody molecule, DOTA-Z(HER2:342-pep2) (K(D) = 65 (p)M) labeled with indium-111, was studied both during continuous and interrupted incubation with HER2-expressing cell lines (SKOV-3, SKBR-3, and BT474). The internalized and membrane bound fractions of Affibody molecule were discriminated by treatment with 4 M of urea solution in 0.2 M of glycine buffer (pH 2.0). Incubation media collected after an interrupted incubation was analyzed for the presence of radiocatabolites. Continuous incubation of tumor cells with (111)In-DOTA-Z(HER2:342-pep2) led to the saturation of HER2 and slow internalization. Sixty (60)- to 80% of the radioactivity remained cell associated 24 hours after interrupted incubation. The rate of Affibody molecule internalization was the same after interrupted incubation, as in the continuous incubation experiments. Internalization of (111) In-DOTA-Z(HER2:342-pep2) was relatively slow. A high level of cellular retention of the tracer was provided by strong binding to cell-surface receptors. These data suggest that good tumor targeting with anti-HER Affibody molecules may be obtained by using short-lived, nonresidualizing labels.

Place, publisher, year, edition, pages
2008. Vol. 23, no 4, 435-442 p.
Keyword [en]
cellular processing, HER2, affibody molecule, indium-111, internalization
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-104566DOI: 10.1089/cbr.2008.0464ISI: 000259167300005PubMedID: 18771347OAI: oai:DiVA.org:uu-104566DiVA: diva2:219948
Available from: 2009-05-28 Created: 2009-05-28 Last updated: 2015-03-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Orlova, Anna
By organisation
Biomedical Radiation Sciences
In the same journal
Cancer Biotherapy and Radiopharmaceuticals
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 216 hits
ReferencesLink to record
Permanent link

Direct link